All News Chiome Bioscience Inc.

Equities

4583

JP3205350006

Delayed Japan Exchange Other stock markets 01:57:53 08/05/2024 BST			5-day change	1st Jan Change
127 ^JPY	+2.42%		+0.79%	-5.93%

04-01	Chiome Bioscience Cancels License Agreements with ADC Therapeutics	MT
02-13	Chiome Bioscience Inc. Announces Entrustment Agreement with Takeda Pharmaceutical Company Limited	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chiome Bioscience Cancels License Agreements with ADC Therapeutics	04-01	MT
Chiome Bioscience Inc. Announces Entrustment Agreement with Takeda Pharmaceutical Company Limited	02-13	CI
Chiome Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-13	CI
Chiome Bioscience Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	11-14	CI
Chiome Bioscience Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	09/08/23	CI
Chiome Bioscience Inc. announced that it has received ¥13.49304 million in funding from Barclays Bank PLC (Tokyo Branch), Growth Capital, Inc.	19/07/23	CI
Chiome Bioscience Inc. announced that it expects to receive Â¥13.49304 million in funding	03/07/23	CI
Chiome Bioscience Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23	CI
Chiome Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/02/23	CI
Chiome Bioscience Inc. Provided Sales Guidance for 2023	14/02/23	CI
Henlius Biotech Terminates License Agreement for Chiome Bioscience's Tumor Drug	17/01/23	MT
Chiome Bioscience Inc. Announces Termination of the License Agreement for Anti-TROP-2 Antibody Development and Commercialization with Shanghai Henlius Biotech, Inc	17/01/23	CI
Chiome Bioscience Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	14/11/22	CI
Chiome Bioscience Reports Results of Cancer Immunotherapy Joint Research	09/09/22	MT
Chiome Bioscience Signs Research and Option Agreement with Heidelberg Pharma	14/07/22	MT
Heidelberg Pharma Enters Research Collaboration Deal With Japan's Chiome Bioscience	13/07/22	MT
Chiome Bioscience : Announcement of target-specific research and option agreement with Heidelberg Pharma	13/07/22	PU
Chiome Bioscience Inc. Announces Conclusion of Target-Specific Research and Option Agreement with Heidelberg Pharma	13/07/22	CI
Japan Index Snaps Three-day Winning Streak on Inflationary Pressures; Kudan Shares Expand 7%	12/07/22	MT
Chiome Bioscience, Rohto Pharmaceutical Sign Deal for Generation of Therapeutic Antibody	12/07/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Chiome Bioscience Inc.

Equities

4583

JP3205350006

All News

Filters